Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1631 1632 1791
This examiner grants 25% of resolved cases
Zanna Maria Beharry is an examiner in Tech Center 1700 and Art Unit 1631. She has a total of 73 resolved cases, which have resulted in an allowance rate of 24.7%. This 24.7% rate suggests a rigorous examination process where applicants face significant hurdles. However, the data shows a very high interview lift of 56.4%. This 56.4% figure suggests that while the initial path to allowance is difficult, direct communication through an interview is a powerful tool for overcoming rejections compared to the 24.7% baseline.
The median days to allowance for her docket is 1508. This 1508 duration reflects a lengthy prosecution period, likely involving multiple rounds of office actions. With 73 resolved cases, the 24.7% allowance rate highlights the challenging nature of Art Unit 1631. Practitioners should strongly consider the 56.4% interview lift as a primary strategy to navigate these challenges. The 1508-day median pendency underscores the need for a persistent approach when working with Examiner Beharry in Tech Center 1700.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18694962 | USE OF HUMAN MESENCHYMAL STEM CELL SHEET IN TREATMENT OF UTERINE SCARS | Non-Final OA | BOE Technology Group Co., Ltd. |
| 18563147 | LUNG ORGANOID MODEL AND METHOD OF USE | Non-Final OA | The Regents of the University of California |
| 17286534 | Soluble Extracellular Matrix Composition and Method for Intravascular Delivery | Final Rejection | The Regents of the University of California |
| 17353049 | COMPOSITIONS AND METHODS FOR AIRWAY TISSUE REGENERATION | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17179643 | LACTIC ACID ADSORBENT AND METHOD FOR REMOVING LACTIC ACID | Non-Final OA | TOHOKU UNIVERSITY |
| 17178470 | AMMONIA ADSORBENT AND METHOD FOR REMOVING AMMONIA | Non-Final OA | TOHOKU UNIVERSITY |
| 17843086 | PERFUSION SYSTEM FOR CORNEAL ENDOTHELIAL CELL GRAFT EVALUATION | Final Rejection | REGENTS OF THE UNIVERSITY OF MINNESOTA |
| 17626728 | ZEBRAFISH DELETION AND COMPOUND MUTANTS AND USES THEREOF | Non-Final OA | The General Hospital Corporation |
| 17992032 | METHOD FOR SEARCHING AND SCREENING FOR TARGET OF ANTI-CANCER AGENT USING NON-HUMAN ANIMAL MODEL HAVING NOG ESTABLISHED CANCER CELL LINE TRANSPLANTED THEREIN | Non-Final OA | CHUGAI SEIYAKU KABUSHIKI KAISHA |
| 16992316 | Hierarchic Neural Microphysiological System for Brain Function and Disorders | Non-Final OA | The Trustees of Columbia University in the City of New York |
| 17430822 | Treating Heart Failure | Final Rejection | Children`s Medical Center Corporation |
| 17617191 | RED BLOOD CELL STORAGE SOLUTIONS, ADDITIVES, AND METHODS FOR IMPROVING THE STORAGE OF RED BLOOD CELLS USING INORGANIC PYROPHOSPHATES | Final Rejection | University of Cincinnati |
| 17925355 | COMPOSITION FOR ENHANCING IMMUNE RESPONSE BY USING ACTIVATION FUNCTION OF DENDRITIC CELLS OF STROMAL VASCULAR FRACTIONS ISOLATED FROM ADIPOSE TISSUES | Non-Final OA | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 17634148 | METHODS FOR MAKING ORGANOID COMPOSITIONS | Non-Final OA | CHILDREN'S HOSPITAL MEDICAL CENTER |
| 17764593 | INDIRECT THREE-DIMENSIONAL CO-CULTURE OF DORMANT TUMOR CELLS AND USES THEREOF | Non-Final OA | UNIVERSITY OF DELAWARE |
| 17917992 | NON-HUMAN ANIMAL SECRETOME MODELS | Final Rejection | University of Pittsburgh - Of the Commonwealth System of Higher Education |
| 17756398 | THYMUS ORGANOIDS BIOENGINEERED FROM HUMAN PLURIPOTENT STEM CELLS | Final Rejection | University of Pittsburgh - of the Commonwealth System of Higher Education |
| 18288505 | COMPOSITIONS AND METHODS FOR RAPID GENERATION OF MODIFIABLE STABLE CELL LINES | Final Rejection | Duke University |
| 18029026 | PARATHYROID GLAND CELLS | Non-Final OA | Takeda Pharmaceutical Company Limited |
| 18572668 | REGULATORY NUCLEIC ACID SEQUENCES | Non-Final OA | ASKBIO INC. |
| 17794747 | STROMA-FREE T CELL DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS | Non-Final OA | THE CHILDREN'S MEDICAL CENTER CORPORATION |
| 18253047 | PANCREAS EXTRACELLULAR MATRIX DERIVED SCAFFOLD FOR CULTURE AND TRANSPLANTATION OF PANCREATIC ORGANOID AND METHOD OF PREPARING THE SAME | Non-Final OA | CELLARTGEN INC. |
| 18473448 | METHOD FOR PRODUCING BIRD PRODUCING HUMAN IMMUNOGLOBULIN FC AND TARGET PROTEIN | Non-Final OA | AVINNOGEN CO., LTD. |
| 17416454 | MEMBRANE FOR SEPARATION OF STEM CELLS FROM BIOLOGICAL SAMPLES, PRODUCTION PROCESS FOR SAID MEMBRANE, AND PROCESS AND DEVICE FOR SEPARATION, COMPRISING SAID MEMBRANE | Final Rejection | BIO-RECELL LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy